Kerry Cleveland, MD
Infectious Disease · Memphis, TNNPI 1114984911
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $358,325 of the $426,308 with a category attached, or 84.1%. AbbVie accounts for 64.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $167,513 and has fallen 55.1% since, to $75,134 in 2025. Among infectious disease clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 526 payments — averaging $810.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$276K
- Merck$118K
- Paratek Pharmaceuticals, Inc.$12K
- Cumberland Pharmaceuticals, Inc.$11K
- Pfizer$10K
- La Jolla Pharmaceutical Company$394
- plus $132 from 2 others
Across 3 payments — averaging $269.03 each. An ownership or investment interest held by the physician or an immediate family member.
- Sitesaver Inc.$807
What the payments were for
- Consulting fees$10,8033%
- Speaking & faculty fees$358,32584%
- Travel & lodging$50,94412%
- Food & beverage$6,1781%
- Education$580%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 330 | $275,632 |
| Merck | 153 | $117,530 |
| Paratek Pharmaceuticals, Inc. | 16 | $11,828 |
| Cumberland Pharmaceuticals, Inc. | 11 | $11,236 |
| Pfizer | 9 | $9,557 |
| La Jolla Pharmaceutical Company | 4 | $394 |
| Comsort, Inc | 1 | $100 |
| Insmed, Inc. | 2 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$426,308 in reported general payments places this provider in the 95th percentile of 156 infectious disease providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Memphis
- Michael GelfandMemphis$486K
- Stephen ThrelkeldMemphis$27K
- Imad OmerMemphis$22K
- Margarita LamotheMemphis$12K
- Daniel MurrellMemphis$12K
- James DaleMemphis$8K
- Michael ThrelkeldMemphis$5K
- Kristie NowakMemphis$2K
- Shirin MazumderMemphis$2K
- Chiemeziem NwanyanwuMemphis$899
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.